European Archives - Page 914 of 981 - European Medical Journal

Continue
EMJ
10 Jul 2015

Towards targeted therapy of chronic lymphocytic leukaemia

Jacqueline Barrientos, MD, of North Shore-LIJ Cancer Institute, Lake Success, NY, summarises recent progress in the treatment of chronic lymphocytic…
EMJ
10 Jul 2015

Melanoma treatment update at ASCO 2015

Axel Hauschild, MD, of University of Schleswig-Holstein, Kiel, Germany, reviews the clinical trial data for new treatments in melanoma presented at the…
EMJ
10 Jul 2015

CheckMate 067: Phase 3 trial of nivolumab in melanoma

University of Nebraska Medical Center, Omaha, NE, discusses the phase 3 CheckMate 067 trial of nivolumab alone or combined with ipilimumab versus…
EMJ
10 Jul 2015

COMBI-d: Phase 3 trial of dabrafenib plus trametinib in BRAF V600E/K-mutated melanoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Georgina Long, BSc, PhD, MBBS, FRACP, of the University of Sydney, Sydney…
EMJ
10 Jul 2015

Phase 3 trial of whole brain radiation therapy in addition to radiosurgery for brain metastases

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Andrew B. Lassman, MD, of Columbia University Medical Center, New York, NY…
EMJ
10 Jul 2015

The treatment landscape of metastatic kidney cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, provides an overview…
EMJ
10 Jul 2015

Phase 3 trial of eribulin versus dacarbazine in leiomyosarcoma and liposarcoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Patrick Schöffski, MD, of University Hospitals Leuven, Leuven, Belgium…
EMJ
10 Jul 2015

Phase 2 trial of lenvatinib and everolimus in metastatic renal cell carcinoma

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, James Larkin, FRCP, PhD, of The Royal Marsden, London, UK, discusses the results…
EMJ
10 Jul 2015

TATTON: Phase 1b trial of combination therapies with AZD9291 in EGFR-mutant lung cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Geoffrey R. Oxnard, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses…
7 Jul 2015

Treatment of Secondary Mitral Regurgitation via Percutaneous Annuloplasty

Functional mitral regurgitation (FMR) is a common occurrence in patients with heart failure (HF). FMR is associated with as much as a 2-fold increase in…